Stephens Kristin 4
4 · Syros Pharmaceuticals, Inc. · Filed Apr 4, 2022
Insider Transaction Report
Form 4
Stephens Kristin
Chief Development Officer
Transactions
- Tax Payment
Common Stock
2022-04-01$1.12/sh−14,115$15,809→ 30,885 total
Footnotes (1)
- [F1]Represents shares used to cover tax withholding on a Restricted Stock Unit release.